VVVan Vo

Van Vo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Van Vo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Edwin C. Oh

    Laboratory of Neurogenetics and Precision Medicine, College of Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.

    5 shared publications
  • Daniel Gerrity

    Southern Nevada Water Authority

    4 shared publications
  • Ching-Lan Chang

    Laboratory of Neurogenetics and Precision Medicine, College of Science, Neuroscience Interdisciplinary Ph.D. program, University of Nevada Las Vegas, Las Vegas, NV 89154

    3 shared publications
  • Jose Yani Itorralba

    Laboratory of Neurogenetics and Precision Medicine, Center for Water Intelligence and Community Health, College of Sciences, University of Nevada Las Vegas, Las Vegas, USA

    3 shared publications
  • Michael A. Moshi

    Laboratory of Neurogenetics and Precision Medicine, College of Science, Neuroscience Interdisciplinary Ph.D. program, University of Nevada Las Vegas, Las Vegas, NV 89154

    3 shared publications
  • Cassius Lockett

    Southern Nevada Health District, Las Vegas, USA

    2 shared publications

Latest Publications

  • Open Access

    Wastewater intelligence predicts the emergence of clinically-relevant and drug-resistant Candidozyma auris at healthcare facilities

    by Ching-Lan Chang, Michael A. Moshi, Quang-Huy Nguyen, Junghun Oh, Ha Nguyen, Pratik Paranjape, Mohammed Abushanab, Austin J. Tang, Jose Yani Itorralba, Lauryn Massic, et al.

    The rapid evolution of antifungal resistance in Candidozyma auris (formerly Candida auris) presents significant challenges for conventional public health surveillance methods, particularly in detecting emergent and highly transmissible drug-resistant variants. Here, using wastewater-based epidemiology tools initially developed during the COVID-19 pandemic, we implement a high-resolution, facility-level early warning system to monitor C. auris infections and resistance patterns. Our evaluation across Southern Nevada demonstrates that upstream sewage monitoring at healthcare facilities provides significant sensitivity (p < 0.001) compared to wastewater treatment plant sampling. By combining amplicon sequencing and MALDI-TOF mass spectrometry, we identify clinically-relevant, resistance-associated variants in wastewater samples, while whole-genome sequencing reveals >90% genomic concordance between 443 wastewater-derived genomes and 2945 clinical isolates. We also detect previously unreported subclades and resistance mutations, including FKS1 Phe635Leu and co-occurring ERG11/FKS1 variants in wastewater samples up to nearly five months before their appearance in clinical settings. Transcriptomic profiling of drug-resistant isolates under antifungal and stress conditions identifies previously uncharacterized adaptation mechanisms, including differential regulation of ribosomal assembly pathways and cell cycle checkpoints. These findings highlight how wastewater intelligence can enhance traditional public health approaches for early detection and monitoring of C. auris outbreaks and antifungal resistance.


  • Open Access

    Wastewater intelligence predicts the emergence of clinically-relevant and drug-resistant Candida auris at healthcare facilities

    by Ching-Lan Chang, Michael A. Moshi, Quang-Huy Nguyen, Junghun Oh, Ha Nguyen, Pratik Paranjape, Mohammed Abushanab, Austin J. Tang, Jose Yani Itorralba, Lauryn Massic, et al.

    The rapid evolution of antifungal resistance in Candida auris presents significant challenges for conventional public health surveillance methods, particularly in detecting emergent and highly transmissible drug-resistant variants. Using wastewater-based epidemiology (WBE) tools initially developed during the COVID-19 pandemic, we implemented a high-resolution facility-level early warning system to monitor C. auris infections and resistance patterns. Our comprehensive evaluation across Southern Nevada demonstrated that upstream sewage monitoring at healthcare facilities provided significant sensitivity (p90% genomic concordance between 443 wastewater-derived genomes and 2,977 clinical isolates. We also detected novel subclades and resistance mutations, including FKS1 Phe635Leu and co-occurring ERG11 / FKS1 variants in wastewater samples up to nearly five months before their appearance in clinical settings. Further transcriptomic profiling of drug-resistant isolates under antifungal and stress conditions identified previously uncharacterized adaptation mechanisms, including differential regulation of ribosomal assembly pathways and cell cycle checkpoints. These findings highlight how wastewater intelligence can substantially enhance traditional public health surveillance approaches for the early and proactive detection and monitoring of C. auris outbreaks and antifungal resistance.


  • Open Access

    Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learning

    by Xiaowei Zhuang, Van Vo, Michael A. Moshi, Ketan Dhede, Nabih Ghani, Shahraiz Akbar, Ching-Lan Chang, Angelia K. Young, Erin Buttery, William Bendik, et al.

    Genome sequencing from wastewater enables accurate and cost-effective identification of SARS-CoV-2 variants. However, existing computational pipelines have limitations in detecting emerging variants not yet characterized in humans. Here, we present an unsupervised learning approach that clusters co-varying and time-evolving mutation patterns to identify SARS-CoV-2 variants. To build our model, we sequence 3659 wastewater samples collected over two years from urban and rural locations in Southern Nevada. We then develop a multivariate independent component analysis (ICA)-based pipeline to transform mutation frequencies into independent sources. These data-driven time-evolving and co-varying sources are compared to 8810 SARS-CoV-2 clinical genomes from Nevadans. Our method accurately detects the Delta variant in late 2021, Omicron variants in 2022, and emerging recombinant XBB variants in 2023. Our approach also reveals the spatial and temporal dynamics of variants in both urban and rural regions; achieves earlier detection of most variants compared to other computational tools; and uncovers unique co-varying mutation patterns not associated with any known variant. The multivariate nature of our pipeline boosts statistical power and supports accurate early detection of SARS-CoV-2 variants. This feature offers a unique opportunity to detect emerging variants and pathogens, even in the absence of clinical testing.


  • Open Access

    Operationalizing SARS-CoV-2 wastewater monitoring to assess traveler health in Las Vegas, Nevada, USA

    by Casey A. Barber, Ching-Lan Chang, Michael A. Moshi, Shahraiz Akbar, Van Vo, Edwin C. Oh, Daniel Gerrity


  • Open Access

    Science Education for the Youth (SEFTY): A Neuroscience Outreach Program for High School Students in Southern Nevada during the COVID-19 Pandemic

    by Nabih Ghani, Hayley Baker, Audrey Huntsinger, Tiffany Chen, Tiffany D. Familara, Jose Yani Itorralba, Fritz Vanderford, Xiaowei Zhuang, Ching-Lan Chang, Van Vo, et al.

    Laboratory outreach programs for K-12 students in the United States from 2020 to 2022 were suspended or delayed due to COVID-19 restrictions. While Southern Nevada also observed similar closures for onsite programs, we and others hypothesized that in-person laboratory activities could be prioritized after increasing vaccine doses were available to the public and masking was encouraged. Here, we describe how the Laboratory of Neurogenetics and Precision Medicine at the University of Nevada Las Vegas (UNLV) collaborated with administrators from a local school district to conduct training activities for high school students during the COVID-19 pandemic. The Science Education for the Youth (SEFTY) program's curriculum was constructed to incorporate experiential learning, fostering collaboration and peer-to-peer knowledge exchange. Leveraging neuroscience tools from our UNLV laboratory, we engaged with 117 high school applicants from 2021 to 2022. Our recruitment efforts yielded a diverse cohort, with >41% Pacific Islander and Asian students, >9% African American students, and >12% multiracial students. We assessed the impact of the SEFTY program through pre- and postassessment student evaluations, revealing a significant improvement of 20.3% in science proficiency (p < 0.001) after participating in the program. Collectively, our laboratory curriculum offers valuable insights into the capacity of an outreach program to actively foster diversity and cultivate opportunities for academic excellence, even in the challenging context of a global pandemic.